Logo image of MORE.AS

MOREFIELD GROUP NV (MORE.AS) Stock Fundamental Analysis

AMS:MORE - Euronext Amsterdam - CWN814651014 - Common Stock - Currency: EUR

0.625  -0.01 (-0.79%)

Fundamental Rating

2

Overall MORE gets a fundamental rating of 2 out of 10. We evaluated MORE against 33 industry peers in the Professional Services industry. MORE has a medium profitability rating, but doesn't score so well on its financial health evaluation. MORE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MORE had positive earnings in the past year.
In the past year MORE had a positive cash flow from operations.
In the past 5 years MORE has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: MORE reported negative operating cash flow in multiple years.
MORE.AS Yearly Net Income VS EBIT VS OCF VS FCFMORE.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

The Return On Assets of MORE (2.91%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 12.28%, MORE is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
MORE has a better Return On Invested Capital (11.92%) than 69.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MORE is in line with the industry average of 11.23%.
Industry RankSector Rank
ROA 2.91%
ROE 12.28%
ROIC 11.92%
ROA(3y)5.52%
ROA(5y)5.61%
ROE(3y)21.44%
ROE(5y)15.2%
ROIC(3y)12.56%
ROIC(5y)N/A
MORE.AS Yearly ROA, ROE, ROICMORE.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.3 Margins

MORE has a Profit Margin (2.17%) which is in line with its industry peers.
MORE has a Operating Margin of 6.77%. This is in the better half of the industry: MORE outperforms 60.61% of its industry peers.
MORE's Gross Margin of 63.68% is in line compared to the rest of the industry. MORE outperforms 48.48% of its industry peers.
Industry RankSector Rank
OM 6.77%
PM (TTM) 2.17%
GM 63.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MORE.AS Yearly Profit, Operating, Gross MarginsMORE.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

MORE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MORE has about the same amount of shares outstanding.
The number of shares outstanding for MORE has been increased compared to 5 years ago.
MORE has a better debt/assets ratio than last year.
MORE.AS Yearly Shares OutstandingMORE.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MORE.AS Yearly Total Debt VS Total AssetsMORE.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

MORE has an Altman-Z score of 1.07. This is a bad value and indicates that MORE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MORE (1.07) is worse than 84.85% of its industry peers.
MORE has a Debt/Equity ratio of 0.98. This is a neutral value indicating MORE is somewhat dependend on debt financing.
MORE has a worse Debt to Equity ratio (0.98) than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACC1.98
WACC6.03%
MORE.AS Yearly LT Debt VS Equity VS FCFMORE.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

MORE has a Current Ratio of 0.77. This is a bad value and indicates that MORE is not financially healthy enough and could expect problems in meeting its short term obligations.
MORE has a worse Current ratio (0.77) than 69.70% of its industry peers.
MORE has a Quick Ratio of 0.77. This is a bad value and indicates that MORE is not financially healthy enough and could expect problems in meeting its short term obligations.
MORE has a worse Quick ratio (0.56) than 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.56
MORE.AS Yearly Current Assets VS Current LiabilitesMORE.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MORE have decreased strongly by -73.91% in the last year.
The Earnings Per Share has been growing slightly by 2.94% on average over the past years.
Looking at the last year, MORE shows a quite strong growth in Revenue. The Revenue has grown by 15.42% in the last year.
EPS 1Y (TTM)-73.91%
EPS 3Y2.94%
EPS 5YN/A
EPS Q2Q%-96.98%
Revenue 1Y (TTM)15.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MORE.AS Yearly Revenue VS EstimatesMORE.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2022 2023 2024 50M 100M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.83, the valuation of MORE can be described as rather expensive.
Based on the Price/Earnings ratio, MORE is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. MORE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.83
Fwd PE N/A
MORE.AS Price Earnings VS Forward Price EarningsMORE.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MORE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.18
MORE.AS Per share dataMORE.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MORE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOREFIELD GROUP NV

AMS:MORE (7/11/2025, 7:00:00 PM)

0.625

-0.01 (-0.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.22%
Ins Owner ChangeN/A
Market Cap6.78M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.83
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 0.69
P/B 0.36
P/tB 0.45
EV/EBITDA 1.18
EPS(TTM)0.03
EY4.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.9
OCFY144.43%
SpS9.86
BVpS1.75
TBVpS1.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.91%
ROE 12.28%
ROCE 18.05%
ROIC 11.92%
ROICexc 13.49%
ROICexgc 15.11%
OM 6.77%
PM (TTM) 2.17%
GM 63.68%
FCFM N/A
ROA(3y)5.52%
ROA(5y)5.61%
ROE(3y)21.44%
ROE(5y)15.2%
ROIC(3y)12.56%
ROIC(5y)N/A
ROICexc(3y)14.8%
ROICexc(5y)N/A
ROICexgc(3y)16.97%
ROICexgc(5y)N/A
ROCE(3y)19.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 1.04
Cap/Depr 165.24%
Cap/Sales 16.24%
Interest Coverage 250
Cash Conversion 55.16%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.56
Altman-Z 1.07
F-Score4
WACC6.03%
ROIC/WACC1.98
Cap/Depr(3y)162.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)12.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.91%
EPS 3Y2.94%
EPS 5YN/A
EPS Q2Q%-96.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-277.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.68%
OCF growth 3YN/A
OCF growth 5YN/A